Concepedia
Statistics
Publications
13
Citations
350
H-Index
10
Active since
2009
Affiliations
Fujian Medical University(Current)
First Affiliated Hospital of Fujian Medical University
Fujian Provincial Hospital
Zhangzhou Municipal Hospital of Fujian Province
Zhongshan Hospital of Xiamen University
Zhi‐Bo Zhang is an author at Fujian Medical University specializing in medicine, oncology, and hepatocellular carcinoma.
Top concepts
MedicineOncologyHepatocellular CarcinomaHepatologyRadiation OncologyPathologyTumor BiologyCancer ResearchNatural SciencesMolecular Biology
Publications per year
2009–2024
Structural basis of BAM-mediated outer membrane β-barrel protein assembly
Chongrong Shen, Shenghai Chang, Qinghua Luo et al. · Nature · 2023 · 80 citations
Proteinlipid Interaction, Protein Assembly, Natural Sciences +6
Transcatheter arterial chemoembolisation combined with lenvatinib plus camrelizumab as conversion therapy for unresectable hepatocellular carcinoma: a single-arm, multicentre, prospective study
Xukun Wu, Lan‐Fang Yang, Yufeng Chen et al. · EClinicalMedicine · 2023 · 74 citations · Full text
Overexpression of Caveolin-1 in Hepatocellular Carcinoma with Metastasis and Worse Prognosis: Correlation with Vascular Endothelial Growth Factor, Microvessel Density and Unpaired Artery
Zhi‐Bo Zhang, Lei Cai, Shuguo Zheng et al. · Pathology & Oncology Research · 2009 · 57 citations
Tumor Biology, Hepatology, Hepatocellular Carcinoma +10
Textbook outcomes of hepatocellular carcinoma patients with sarcopenia: A multicenter analysis
Di-Hang Wu, Cheng‐Yu Liao, Danfeng Wang et al. · European Journal of Surgical Oncology · 2022 · 21 citations
Surgical Oncology, Hepatology, Hepatocellular Carcinoma Patients +11
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors
Zhen-Xin Zeng, Jiayi Wu, Junyi Wu et al. · Hepatology International · 2023 · 20 citations
Medicine, Unresectable Hcc Patients, Pharmacology +6
1–5 of 13